Back to Search Start Over

The BENEFIT Trial: Where Do We Go from Here?

Authors :
Pecoul, Bernard
Batista, Carolina
Stobbaerts, Eric
Ribeiro, Isabella
Vilasanjuan, Rafael
Gascon, Joaquim
Pinazo, Maria Jesus
Moriana, Silvia
Gold, Silvia
Pereiro, Ana
Navarro, Miriam
Torrico, Faustino
Bottazzi, Maria Elena
Hotez, Peter J.
Source :
PLoS Neglected Tropical Diseases. 2/25/2016, Vol. 10 Issue 2, p1-4. 4p.
Publication Year :
2016

Abstract

The author discusses the trial for Benznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) which evaluates the safety and efficacy of benznidazole for the treatment of patients with Chagasic cardiomyopathy. Topics discussed include the benefits of benznidazole for cardiac disease prevention, the polymerase chain reaction (PCR) conversion rates among Chagas disease patients in Brazil, and the role of comorbidities for its treatment.

Subjects

Subjects :
*CHAGAS' disease treatment
*CHAGAS' disease
*PREVENTION of heart diseases
*POLYMERASE chain reaction
*COMORBIDITY
*PATIENTS

Details

Language :
English
ISSN :
19352727
Volume :
10
Issue :
2
Database :
Academic Search Index
Journal :
PLoS Neglected Tropical Diseases
Publication Type :
Academic Journal
Accession number :
113286763
Full Text :
https://doi.org/10.1371/journal.pntd.0004343
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details